Stock BLUEJET BLUE JET HEALTHCARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Blue Jet Healthcare Limited

Equities

BLUEJET

INE0KBH01020

Pharmaceuticals

End-of-day quote NSE India S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
382.3 INR +1.97% Intraday chart for Blue Jet Healthcare Limited +1.78% +3.86%
May. 25 Blue Jet Healthcare Limited Recommends Final Dividend for the Financial Year Ended 31 March 2024 CI
May. 25 Blue Jet Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI

Valuation

Fiscal Period: March 2024 2025 2026
Capitalization 1 66,316 - -
Enterprise Value (EV) 1 63,234 63,735 61,617
P/E ratio 40.6 x 29.1 x 23.2 x
Yield 0.26% 0.76% 1.41%
Capitalization / Revenue 9.33 x 6.61 x 5.33 x
EV / Revenue 8.89 x 6.35 x 4.95 x
EV / EBITDA 27.6 x 20.2 x 15.5 x
EV / FCF 92.5 x -171 x 88.4 x
FCF Yield 1.08% -0.58% 1.13%
Price to Book 7.86 x 6.42 x 5.29 x
Nbr of stocks (in thousands) 173,465 - -
Reference price 2 382.3 382.3 382.3
Announcement Date 5/25/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2023 2024 2025 2026
Net sales 1 - 7,116 10,029 12,453
EBITDA 1 - 2,292 3,158 3,980
EBIT 1 - 2,011 2,732 3,417
Operating Margin - 28.27% 27.24% 27.44%
Earnings before Tax (EBT) 1 - 2,201 3,050 3,839
Net income 1 1,600 1,638 2,282 2,905
Net margin - 23.01% 22.76% 23.32%
EPS 2 9.230 9.440 13.15 16.48
Free Cash Flow 1 - 684 -372 697
FCF margin - 9.61% -3.71% 5.6%
FCF Conversion (EBITDA) - 29.84% - 17.51%
FCF Conversion (Net income) - 41.77% - 24%
Dividend per Share 2 - 1.000 2.900 5.400
Announcement Date 7/10/23 5/25/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2024 Q4
Net sales 1 1,971
EBITDA 1 613
EBIT 1 520
Operating Margin 26.38%
Earnings before Tax (EBT) 1 564
Net income 1 387
Net margin 19.63%
EPS 2 2.200
Dividend per Share -
Announcement Date -
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2023 2024 2025 2026
Net Debt 1 - - - -
Net Cash position 1 - 3,186 2,581 4,699
Leverage (Debt/EBITDA) - - - -
Free Cash Flow 1 - 684 -372 697
ROE (net income / shareholders' equity) - 22.4% 28.1% 27%
ROA (Net income/ Total Assets) - 17.8% 19.8% 19.3%
Assets 1 - 9,197 11,542 15,041
Book Value Per Share 2 - 48.70 59.60 72.30
Cash Flow per Share - - - -
Capex 1 - 1,729 1,788 1,667
Capex / Sales - 24.29% 17.83% 13.38%
Announcement Date 7/10/23 5/25/24 - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
382.3 INR
Average target price
406.7 INR
Spread / Average Target
+6.37%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
BLUE JET HEALTHCARE LIMITED Stock Blue Jet Healthcare Limited
+3.86% 795M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+40.73% 739B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.83% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.30% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.15% 318B
ABBVIE INC. Stock AbbVie Inc.
+4.05% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.00% 240B
NOVARTIS AG Stock Novartis AG
+9.78% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-5.52% 206B
AMGEN INC. Stock Amgen Inc.
+6.17% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BLUEJET Stock
  4. Financials Blue Jet Healthcare Limited